Friday, August 30, 2013

Synthetic Metaphors

Early in its development, the field of synthetic biology adopted the language of engineering to describe what its practitioners do - or dream of eventually doing.  Phrases like "genetic circuit," "programming DNA," and "cellular machines," became commonplace in the field.  Although synthetic biologists hope to refashion biology into a more predictable and controllable than it currently is, much progress needs to be made, and the complexities that are biology often defy prediction and control.

On August 28, 2013, Nature published an article, entitled "Communication:  Mind the Metaphor," that elegantly analyzes the advantages and pitfalls of adoping engineering metaphors into a field as messy and complicated as biology.  The article further points out the sociological role that language has played in the field:
Despite the necessary fluidity surrounding their use, engineering metaphors have proved so robust as to create an identity among merging research communities. Indeed, the power of metaphors resides in their ability to serve as translational devices between different articulations of science — an essential function when cross-field collaboration results in the building of a new discipline, as has been the case for synthetic biology.

As synthetic biology continues to evolve, some engineering words, phrases, and concepts will inevitably prove their worth, while others will be revealed as inapt.  Vocabulary and ideas from other fields may fill these gaps.  However, what the adoption of engineering language has revealed, at least in the case of synthetic biology, is that breaks with the past can sometimes foster commonalities among formerly disparate groups of scientists.

Friday, August 23, 2013

Data About Patents

All major countries in the world have patent systems, and most of these must abide by treaties like the Paris Convention for the Protection of Industrial Property and the Patent Cooperation Treaty.  All members of the World Trade Organization ("WTO") are legally obligated to ensure that their patent systems meet the minimal requirements of the Agreement on Trade Related Aspects of Intellectual Property Rights ("TRIPS").  It would thus be reasonable to assume that patents do, indeed, spur technological innovation.  However, solid evidence for this assumption has proved elusive.  In several experimental studies my colleague, Bill Tomlinson, and I conducted, entitled "Patents and the Regress of Useful Arts," "Patent Expertise and the Regress of Useful Arts," and "Property Rules, Liability Rules, and Patents: One Experimental View of the Cathedral," our data failed to show that patents spur technological innovation.

Patents may indeed work well to encourage new inventions, but evidence to support this would be beneficial in helping to guide wise public policy.To this end, telecommunications firm Qualcomm Incorporated announced on August 22, 2013, that it donated $2,000,000 to the Searle Center on Law, Regulation, and Economic Growth at Northwestern University to fund research into the connections between patent protection and technological innovation. As the press release states,
The grant will make it possible for the Searle Center to create a series of related databases to collate information regarding standards, licensing, litigation and markets for patents. Scholars will be able to use these data to better understand how inventive activity occurs, how it is commercialized and what might be done to facilitate future innovation. The grant also funds a series of conferences and roundtables to examine and improve research in the field.
Research into how patent systems actually function is fundamentally important to social welfare.  If patents work well, then countries can confidently use them to increase the rate of technological development.  If they do not accomplish this goal - or even thwart it - then wise public policy may employ other approaches, such as open, user, and collaborative innovation.  Reliable data on patent systems is vital.  More research is needed.  Society will benefit, whatever the results may be.  

Thursday, August 22, 2013

Patent Litigation Situation

The United States Government Accountability Office ("GAO") finally released its study of trends in, and drivers of, U.S. patent litigation on August 22, 2013.  Employing an empirical approach, this study, entitled "INTELLECTUAL PROPERTY - Assessing Factors That Affect Patent Infringement Litigation Could Help Improve Patent Quality," may serve as an antidote to some of the wilder claims that the patent system has become overwhelmed by patent trolls, vague software patents, and runaway federal courts.  The GAO study concludes as follows:
Public discussion surrounding patent infringement litigation often focuses on the increasing role of NPEs. However, our analysis indicates that regardless of the type of litigant, lawsuits involving software-related patents accounted for about 89 percent of the increase in defendants between 2007 and 2011, and most of the suits brought by PMEs involved software-related patents. This suggests that the focus on the identity of the litigant—rather than the type of patent—may be misplaced. PTO’s recent efforts to work with the software industry to more uniformly define software terminology and make it easier to identify relevant patents and patent owners may strengthen the U.S. patent system. Further, PTO has available internal data on the patent examination process that could be linked to litigation data, and a 2003 National Academies study reported that using these types of data together could provide useful insights into patent quality. Examining the types of patents and issues in dispute represents a potentially valuable opportunity to improve the quality of issued patents and the patent examination process and to further strengthen the U.S. patent system.
In recent years, the patent system has attracted unprecedented attention from governments hoping to determine how best to foster technological innovation.  While proprietary innovation may play an important role, it is equally imperative that governments devote substantial attention to fostering open, user, and collaborative innovation, all of which occur without, or sometimes despite, the patent system, and contribute myriad new goods and services.  Innovation is vitally important to improving human welfare.  Determining which policies, or mixture of policies, best achieve innovation should be a paramount public policy goal.

Monday, August 19, 2013

Rockford Warned About Electronic Surveillance

No television show has foretold the future better than The Rockford Files, which ran as episodes from 1974 to 1980, and then as made-for-TV movies from 1994 to 1999.  Iconoclastic from the start, the series depicted an ex-con private detective, James Rockford (played by James Garner), who lived in a trailer in a seaside Malibu parking lot.  Rockford was closest to his father, Rocky (a retired trucker), a small-time conman (the ironically-named Angel), and an attorney (Beth), but had an eclectic circle of friends who ranged from policemen to mafiosi, and everything in between.  Breaking existing conventions of good and evil, The Rockford Files often scandalously depicted the criminals, police, and (especially) governments and corporations as morally equivalent, as well as insidious threats to the rights of ordinary citizens.  David Chase, the genius responsible for another genre-buster, The Sopranos, wrote and produced for The Rockford Files, and, the former resounds with loud echoes of the latter.

The current scandal over the breathtaking scope of the National Security Agency's electronic surveillance efforts was presaged in the final two episodes of season 4 ("The House on Willis Avenue"), the villain of which was an extremely extralegal corporation building a huge (for 1978) computer surveillance system for gathering, analyzing, and selling sensitive personal data on every person.  The closing credits ended with the following warning (attributed to "Member, U.S. Privacy Protection Commission"):
Secret information centers, building dossiers on individuals exist today.  You have no legal right to know about them, prevent them, or sue for damages.  Our liberty may well be the price we pay for permitting this to continue unchecked.
History repeats.  Is anything learned?  One truth abides:  The Rockford Files was way ahead of its time.

Wednesday, August 7, 2013

Double Standards-Setting

On June 4, 2013, the United States International Trade Commission ("ITC") decided In the Matter of CERTAIN ELECTRONIC DEVICES, INCLUDING WIRELESS COMMUNICATION DEVICES, PORTABLE MUSIC AND DATA PROCESSING DEVICES, AND TABLET COMPUTERS (Inv. No. 337-TA-794).  In its decision, the ITC, a hybrid federal court-agency with authority to regulate trade via imports and sales, decided to issue an exclusion order banning imports, and a cease and desist order forbidding sales, of some older Apple Inc. mobile electronic devices on the grounds that they infringed claims of patents owned by Samsung Electronics Co..  Apple invoked as a defense Samsung's alleged violation of its obligations to make license standards-essential patents to Apple under fair reasonable and non-discriminatory ("FRAND") terms.

Growing interest by governments,  industry, and scholars in the roles of patents in standards setting, and particularly the possible dangers posed to healthy competition by abuses of patents essential to widely-adopted technical standards, has raised the consciousness of terms like FRAND and its less restrictive cousin reasonable and non-discriminatory ("RAND").  The National Academies have been intensively studying the issue, including its impacts on important emerging technologies like synthetic biology.  Thus, it was only somewhat surprising that President Barack Obama, via United States Trade Representative Irving A. Williamson, decided to "disapprove" (that is, veto) the decision of the ITC, thus allowing Apple to continue to import and sell goods the ITC found to infringe claims of Samsung's patents.

Although the disapproval letter issued by Williamson includes a mandatory reaffirmation of U.S. support for intellectual property rights and innovation, it also raises the specter of standards-essential patent abuse.  The tension between strong patent rights and competition will always be with us.  Now standards setting has become a significant new front in this conflict.

Tuesday, August 6, 2013

GDIP

Intangibles have become ever more tangible to economies.  In fact, invention, innovation, creativity, and research, and the patents, copyrights, trademarks, trade secrets, and know how whose official rationales are to promote and protect them are already major forces driving economic growth.  The United States Bureau of Economic Analysis ("BEA") formally recognized the importance of intangibles in its July 31, 2013, revision of how it calculates the gross domestic product ("GDP").  In a press release, the BEA describes several ways in which intangibles will henceforth be valued more highly:
* Expenditures by business, government, and nonprofit institutions serving households (NPISH) for research and development (R&D) are recognized as fixed investment. The new treatment improves BEA’s measures of fixed investment and allows users to better measure the effects of innovation and intangible assets on the economy.
* Similarly, expenditures by private enterprises for the creation of entertainment, literary, and artistic originals are recognized as fixed investment, further expanding BEA’s measures of intangible assets.
* In the NIPA fixed investment tables, a new category of investment, "intellectual property products," consists of research and development; entertainment, literary, and artistic originals; and software.
The BEA also notes that weighting intangibles more heavily in its new metric leads to upward revisions in both current and past GDP calculations.  To adapt Dire Straits (and Sting) ever so slightly, that's as close as governments can get these days to "Money for nothin' and growth for free."

Wednesday, July 31, 2013

Off-Label Mis-Use

The coffers of the United States federal government will swell by $490.9 billion now that Wyeth Pharmaceuticals, Inc. (a division of Pfizer, Inc.), has settled a case brought against it for allegedly violating the Food, Drug & Cosmetics Act.  On July 30, 2013, the settlement was made public in a press release on the U.S. Justice Department's website. The press release outlines the allegations against Wyeth as follows:
The Federal Food, Drug and Cosmetic Act (FDCA) requires a company such as Wyeth to specify the intended uses of a product in its new drug application to the FDA. Once approved, a drug may not be introduced into interstate commerce for unapproved or “off-label” uses until the company receives FDA approval for the new intended uses. In 1999, Wyeth received approval from the FDA for Rapamune use in renal (kidney) transplant patients. However, the information alleges, Wyeth trained its national Rapamune sales force to promote the use of the drug in non-renal transplant patients. Wyeth provided the sales force with training materials regarding non-renal transplant use and trained them on how to use these materials in presentations to transplant physicians. Then, Wyeth encouraged sales force members, through financial incentives, to target all transplant patient populations to increase Rapamune sales.
The press release summarizes the terms of the settlement between Wyeth and the Justice Department:
Wyeth Pharmaceuticals Inc., a pharmaceutical company acquired by Pfizer, Inc. in 2009, has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by the U.S. Food and Drug Administration (FDA), the Justice Department announced today. Rapamune is an “immunosuppressive” drug that prevents the body’s immune system from rejecting a transplanted organ.
Details of how the total penalty was calculated are also provided in the press release:
Wyeth has pleaded guilty to a criminal information charging it with a misbranding violation under the FDCA. The resolution includes a criminal fine and forfeiture totaling $233.5 million. Under a plea agreement, which has been accepted by the U.S. District Court in Oklahoma City, Wyeth has agreed to pay a criminal fine of $157.58 million and forfeit assets of $76 million.

The resolution also includes civil settlements with the federal government and the states totaling $257.4 million. Wyeth has agreed to settle its potential civil liability in connection with its off-label marketing of Rapamune. The government alleged that Wyeth violated the False Claims Act, from 1998 through 2009, by promoting Rapamune for unapproved uses, some of which were not medically accepted indications and, therefore, were not covered by Medicare, Medicaid and other federal health care programs. These unapproved uses included non-renal transplants, conversion use (switching a patient from another immunosuppressant to Rapamune) and using Rapamune in combination with other immunosuppressive agents not listed on the label. The government alleged that this conduct resulted in the submission of false claims to government health care programs. Of the amounts to resolve the civil claims, Wyeth will pay $230,112,596 to the federal government and $27,287,404 to the states.
There are several possible explanation for why Wyeth decided to settle.  One is that it calculated its odds of prevailing against the Justice Department as unacceptably low.  Another is that Wyeth decided it would be best for its business prospects to remove the shadow the allegations had cast over it.  A final, more fanciful, possibility is that Wyeth felt distracted hampered by the high-profile dispute;  as Shakespeare wrote, "We do not keep the outward form of order, where there is deep disorder in the mind."

Tuesday, July 30, 2013

Sensitive Secrets And The Enemy

Private First Class Bradley Manning was found guilty of several very serious charges in a United States military court on July 30, 2013.  Incarceration looms large for him.  However, Manning was acquitted of the extremely serious charge of "aiding the enemy."  The prosecution's theory in pursuing the latter charge was that the sensitive military information Manning published to the whole world could assist specific enemies of the U.S., including terrorists.  However, the court was not persuaded.  If he had turned the same information over only to specific enemies, the result might have been different.  This may seem inconsequential in the face of the severe penalties facing Manning.  However, if upheld by other courts, the principle of general publication not "aiding the enemy" could be vitally important to other potential wikileakers.

Monday, July 29, 2013

Nosy Dinosaur

A beautiful artist rendition of a dinosaur always deserves recognition.  A recently-discovered late Cretaceous ceratopsian relative of Triceratops, named Nasutoceratops ("large-nosed horned-face"), is depicted in a July 17, 2013, article in Science.

Sunday, July 28, 2013

Vitamin G(ene)

On July 28, 2013, the New York Times published a fascinating article, entitled "A Race to Save the Orange by Altering Its DNA," covering the biggest dilemma currently faced by orange growers:  whether or not opt for genetic engineering to save commercial orange trees from "citrus greening."  The spread of eubacterium Candidatus liberibacter asiaticus has cast a dark shadow over the large orange growing and processing industry.  Market penetration of genetically-modified ("GM") food has grown rapidly around the world.  Although Europe has been a laggard, consumers in the United States have been relatively enthusiastic - or, at least, agnostic - about GM food.  The orange industry may be embracing GM oranges as its salvation.  How long will it be before parents are worrying about their children eating enough "Vitamin G(ene)"?